Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733069 · ClinicalTrials.gov registry record
Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 1,912
- Enrollment target
NCT01733069 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 1,912 participants.
The verdict
NCT01733069 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 1,912 participants
- Enrollment target
Study Summary
The objectives of this study are to establish the performance characteristics of the AC2 (APTIMA Combo 2) Assay on the PANTHER System for the sample types cleared for use on the TIGRIS and DTS (Direct Tube Sampling) Systems and to demonstrate the repeatability and reproducibility of the AC2 Assay on the PANTHER System.
Interventions
- DEVICE APTIMA COMBO 2 Assay (AC2 Assay)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,912 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01733069
The ClinicalTrials.gov registry entry for NCT01733069 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,912 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APTIMA COMBO 2 Assay (AC2 Assay) is the first listed.
NCT01733069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01733069 about?
NCT01733069 is a clinical study titled "Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System". The objectives of this study are to establish the performance characteristics of the AC2 (APTIMA Combo 2) Assay on the PANTHER System for the sample types cleared for use on the TIGRIS and DTS (Direct Tube Sampling) Systems and to demonstrate the repeatability and reproducibility of the AC2 Assay on...
What is the current status of trial NCT01733069?
This trial is currently completed. The enrollment target is 1,912 participants. The study started on 2010-11. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01733069?
The interventions under investigation include: APTIMA COMBO 2 Assay (AC2 Assay) (DEVICE).
Who is sponsoring clinical trial NCT01733069?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.